Education and income are associated with long-term outcome in the metabolic dysfunction-associated steatotic liver disease population

被引:1
|
作者
Zhao, Qianwen [1 ]
Deng, Yunlei [2 ]
机构
[1] Sichuan Univ, Univ Oxford Huaxi Joint Ctr Gastrointestinal Canc, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Peoples R China
[2] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Nephrol, Affiliated Hosp, Chengdu, Peoples R China
关键词
D O I
10.1111/ggi.14719
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:975 / 976
页数:2
相关论文
共 50 条
  • [31] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [32] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [33] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [34] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [35] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [36] Low thyroid function is associated with metabolic dysfunction-associated steatotic liver disease
    Wang, Shuo
    Xia, Ding
    Fan, Hong
    Liu, Zhenqiu
    Chen, Ruilin
    Suo, Chen
    Zhang, Tiejun
    JGH OPEN, 2024, 8 (02):
  • [37] Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomy
    Kong, Qingyan
    Yang, Jiahui
    Kong, Diao
    Hu, Huanrui
    Li, Bei
    Peng, Wei
    Chen, Zheyu
    HEPATOBILIARY SURGERY AND NUTRITION, 2025,
  • [38] Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
    Armandi, Angelo
    Sanavia, Tiziana
    Younes, Ramy
    Caviglia, Gian Paolo
    Rosso, Chiara
    Govaere, Olivier
    Liguori, Antonio
    Francione, Paolo
    Gallego-Duran, Rocio
    Ampuero, Javier
    Pennisi, Grazia
    Aller, Rocio
    Tiniakos, Dina
    Burt, Alastair
    David, Ezio
    Vecchio, Fabio
    Maggioni, Marco
    Cabibi, Daniela
    Mcleod, Duncan
    Pareja, Maria Jesus
    Zaki, Marco Y. W.
    Stal, Per
    Kechagias, Stergios
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Grieco, Antonio
    Miele, Luca
    Fariselli, Piero
    Eslam, Mohammed
    Petta, Salvatore
    Hagstroem, Hannes
    George, Jacob
    Schattenberg, Joern M.
    Romero-Gomez, Manuel
    Anstee, Quentin Mark
    Bugianesi, Elisabetta
    GUT, 2024, 73 (05) : 825 - 834
  • [39] The Impact of Long-Term Aspirin Use on Outcomes Among Hospitalized Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Oum, Muhamad
    Iqbal, Humzah
    Haddadin, Rakahn
    Samhoun, Jalal
    Aftab, Fatimah
    Iqbal, Haroon
    Haidary, Hasib
    Alsawaf, Yahya
    Albuni, Mhd Kutaiba
    Sawaf, Bisher
    Sekhon, Sommer
    Saab, Sammy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1435 - S1435
  • [40] High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease
    Hu, Jingjing
    Du, Yuteng
    Zhou, Yidan
    Wang, Huiying
    SCIENTIFIC REPORTS, 2024, 14 (01):